Press release
Breast Cancer Drugs Market Set to Reach $58.23 Billion by 2029 with 7.8% Yearly Growth
Breast Cancer Drugs Market Research
In recent years, the market size for breast cancer medications has seen robust growth. It is projected to increase from $39.66 billion in 2024 to $43.14 billion in 2025, representing a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth during the historic period include the rising prevalence of breast cancer, progress in research and development, improvements in screening and early detection, changes in treatment guidelines, and expansion of healthcare infrastructure.
In the near future, the market size of breast cancer drugs is anticipated to see robust growth. It is projected to increase to a value of $58.23 billion in 2029, with a compound annual growth rate (CAGR) of 7.8%. The increased growth in this forecast period is linked to the increasing aging population, developing markets, favorable policies and regulations, as well as patient advocacy and awareness. The forecast period will also see significant trends such as precision medicine, immunotherapies and targeted therapies, drug pipeline and clinical trials, combo therapies, treatments driven by biomarkers, and advancements such as telemedicine and remote monitoring.
What Are the Forces Behind the Rapid Growth of the Breast Cancer Drugs Market?
The escalating incidences of breast cancer are propelling the growth of the market for breast cancer drugs. Breast cancer develops from cells within the breast, when these cells proliferate in an uncontrolled manner, creating a tumor that can often be palpable or visible on imaging tests. The surge in breast cancer incidences can be attributed to a mix of elements, such as aging populations, altered lifestyles, genetic susceptibilities, and enhanced diagnostic methods. Drugs for treating breast cancer fortify the fight against this disease by zeroing in on cancerous cells, restraining tumor enlargement, halting the proliferation of cancer, and boosting patient survival rates through customized treatments. For example, figures from the National Center for Biotechnology Information, a government agency in the US, reveal that by 2040 the annual tally of fresh breast cancer diagnoses is projected to surge by more than 40%, amounting to nearly 3 million. Aspects such as heredity, age, and lifestyle are responsible for breast cancer, and it is predominantly prevalent in developed countries. The rising number of breast cancer diagnoses amplifies the need for drugs to treat this condition, thereby fueling the expansion of the market for breast cancer drugs.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2566&type=smp
Who Are the Dominant Companies Influencing Breast Cancer Drugs Market Trends?
Major companies operating in the breast cancer drugs market include F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca PLC, Eli Lilly and Company Inc., Biocon Limited, Merck & Co. Inc., Genzyme Corporation, Johnson & Johnson, MacroGenics Inc., Celldex Therapeutics Inc., Onyx Pharmaceuticals Inc., BioNumerik Pharmaceuticals Inc., AbbVie Inc., Pfizer Inc., OncoGenex Pharmaceuticals Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Apthera Inc., Oncothyreon Inc., BiPar Sciences Inc., Puma Biotechnology Inc., Sanofi S.A., Genentech Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., Accord Healthcare Limited, Alkem Laboratories Limited, Natco Pharma Limited, Fresenius Kabi AG, Lupin Limited, Glenmark Pharmaceuticals Limited
How Is the Breast Cancer Drugs Market Evolving?
Breast cancer drug producers are becoming more collaborative and forming partnerships with other firms to better share technology, resources, and information about their products in order to grow their businesses. A prime example is AstraZeneca, who agreed to a collaboration agreement valued at $6.9 billion aimed at the creation of a breast cancer treatment compound. The terms of their agreement dictate that they will be jointly responsible for the development of the drug trastuzumab deruxtecan, and both will bear the costs associated with its development and global commercialization. Similarly, Novartis has also chosen to collaborate, but with IBM Watson Health, to facilitate the development of a program aimed at determining the most effective drug combinations and sequences for patient care.
What Are the Different Segmentations in the Breast Cancer Drugs Market?
The breast cancer drugs market covered in this report is segmented -
1) By Type: Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels
3) By End User: Ambulatory, Hospitals, Clinics, Other End-Users
Subsegments:
1) By Metastatic Breast Cancer: Hormone Receptor Positive Metastatic Breast Cancer, HER2 Positive Metastatic Breast Cancer, Triple Negative Metastatic Breast Cancer
2) By Triple Negative Breast Cancer: Chemotherapy-Based Treatments, Immunotherapy-Based Treatments, Targeted Therapy
3) By Others: Ductal Carcinoma In Situ (DCIS), Invasive Ductal Carcinoma (IDC), Inflammatory Breast Cancer (IBC), Breast Cancer During Pregnancy, Other Subtypes (Lobular Carcinoma, Paget's Disease of the Breast)
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report
Which Region Is at the Forefront of the Breast Cancer Drugs Market?
North America was the largest region in the breast cancer drugs market in 2023. The Middle East is expected to be the fastest-growing region in the breast cancer drugs market during the forecast period. The regions covered in the breast cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Is Covered In The Breast Cancer Drugs Global Market Report?
- Market Size Analysis: Analyze the Breast Cancer Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Breast Cancer Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Breast Cancer Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Breast Cancer Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2566
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Drugs Market Set to Reach $58.23 Billion by 2029 with 7.8% Yearly Growth here
News-ID: 3871357 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Breast
Breast Health Monitoring App Market to Witness a Pronounce Growth during 2024-20 …
The latest market intelligence report published by WMR with the title "Global Breast Health Monitoring App Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Healthcare and Pharmaceuticals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Breast Health Monitoring App Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y…
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer …
FOR IMMEDIATE RELEASE
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer During Breast Cancer Awareness Month
Liverpool, UK - October, 2023 - Phil Alderson, a primary survivor of male breast cancer, is taking bold steps this Breast Cancer Awareness Month to raise awareness of this often overlooked aspect of the disease. With a homemade cardboard sign that reads "Check Your Pecks," Phil has taken to the streets of…
Breast Health Monitoring App Market Recent Trends, In-depth Analysis, Size, and …
According to The Worldwide Market Reports, the Latest research report on "Breast Health Monitoring App Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Breast Health Monitoring App Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore,…
Breast Pumps Market - Nurturing Convenience: Revolutionizing Breast Pump Technol …
Newark, New Castle, USA - new report, titled Breast Pumps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Breast Pumps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Breast Pumps market. The report offers an overview of the market, which…
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues.
Download Free PDF Brochure on Brest Imaging Market Report Now…
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to…
